Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)

Status:
Terminated

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Primary Objective: To assess the long term safety and tolerability of SAR339658 Secondary Objective: To assess the long term efficacy of SAR339658

Phase 2

Sanofi